197 related articles for article (PubMed ID: 23994755)
21. Assessment of DNA damage in Ehlrich carcinoma after treatment with doxorubicin encapsulated in nanoscales thermosensitive liposomes in combination with localized hyperthermia.
Rageh MM; Shafaa MW; Elhefnawy MR; El-Nagdy MS
Gen Physiol Biophys; 2016 Jul; 35(3):311-22. PubMed ID: 27174899
[TBL] [Abstract][Full Text] [Related]
22. Hyperthermia sensitization and proton beam triggered liposomal drug release for targeted tumor therapy.
Fernando R; Maples D; Senavirathna LK; Zheng Y; Polf JC; Benton ER; Bartels KE; Piao D; Ranjan A
Pharm Res; 2014 Nov; 31(11):3120-6. PubMed ID: 24852892
[TBL] [Abstract][Full Text] [Related]
23. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin.
Tagami T; Ernsting MJ; Li SD
J Control Release; 2011 Jun; 152(2):303-9. PubMed ID: 21338635
[TBL] [Abstract][Full Text] [Related]
24. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity.
Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q
J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502
[TBL] [Abstract][Full Text] [Related]
25. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
[TBL] [Abstract][Full Text] [Related]
26. Doxorubicin and Indocyanine Green Loaded Hybrid Bicelles for Fluorescence Imaging Guided Synergetic Chemo/Photothermal Therapy.
Lin L; Liang X; Xu Y; Yang Y; Li X; Dai Z
Bioconjug Chem; 2017 Sep; 28(9):2410-2419. PubMed ID: 28810733
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of doxorubicin thermosensitive liposomes (40 degrees C) and local hyperthermia on rat rhabdomyosarcoma.
Morita K; Zywietz F; Kakinuma K; Tanaka R; Katoh M
Oncol Rep; 2008 Aug; 20(2):365-72. PubMed ID: 18636199
[TBL] [Abstract][Full Text] [Related]
28. Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity.
Kheirolomoom A; Mahakian LM; Lai CY; Lindfors HA; Seo JW; Paoli EE; Watson KD; Haynam EM; Ingham ES; Xing L; Cheng RH; Borowsky AD; Cardiff RD; Ferrara KW
Mol Pharm; 2010 Dec; 7(6):1948-58. PubMed ID: 20925429
[TBL] [Abstract][Full Text] [Related]
29. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
[TBL] [Abstract][Full Text] [Related]
30. pH-sensitive charge-conversional and NIR responsive bubble-generating liposomal system for synergetic thermo-chemotherapy.
Chen MM; Song FF; Feng M; Liu Y; Liu YY; Tian J; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2018 Jul; 167():104-114. PubMed ID: 29631221
[TBL] [Abstract][Full Text] [Related]
31. Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation.
Gasselhuber A; Dreher MR; Partanen A; Yarmolenko PS; Woods D; Wood BJ; Haemmerich D
Int J Hyperthermia; 2012; 28(4):337-48. PubMed ID: 22621735
[TBL] [Abstract][Full Text] [Related]
32. Hyperthermia mediated liposomal drug delivery.
Ponce AM; Vujaskovic Z; Yuan F; Needham D; Dewhirst MW
Int J Hyperthermia; 2006 May; 22(3):205-13. PubMed ID: 16754340
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermia.
Al-Ahmady ZS; Chaloin O; Kostarelos K
J Control Release; 2014 Dec; 196():332-43. PubMed ID: 25456832
[TBL] [Abstract][Full Text] [Related]
34. Near-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy.
You J; Zhang P; Hu F; Du Y; Yuan H; Zhu J; Wang Z; Zhou J; Li C
Pharm Res; 2014 Mar; 31(3):554-65. PubMed ID: 24022681
[TBL] [Abstract][Full Text] [Related]
35. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
Ning S; Macleod K; Abra RM; Huang AH; Hahn GM
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030
[TBL] [Abstract][Full Text] [Related]
36. Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes.
Cheung CCL; Ma G; Ruiz A; Al-Jamal WT
J Vis Exp; 2020 Mar; (157):. PubMed ID: 32202528
[TBL] [Abstract][Full Text] [Related]
37. Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in vitro and in vivo.
Zhao YZ; Dai DD; Lu CT; Lv HF; Zhang Y; Li X; Li WF; Wu Y; Jiang L; Li XK; Huang PT; Chen LJ; Lin M
Drug Dev Ind Pharm; 2012 Sep; 38(9):1090-8. PubMed ID: 22188116
[TBL] [Abstract][Full Text] [Related]
38. Functionalized graphene oxide-based thermosensitive hydrogel for magnetic hyperthermia therapy on tumors.
Zhu X; Zhang H; Huang H; Zhang Y; Hou L; Zhang Z
Nanotechnology; 2015 Sep; 26(36):365103. PubMed ID: 26291977
[TBL] [Abstract][Full Text] [Related]
39. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
40. Liposomal doxorubicin combined with regional hyperthermia: reducing systemic toxicity and improving locoregional efficacy in the treatment of solid tumors.
Dvorak J; Zoul Z; Melichar B; Petera J; Vesely P; Vosmik M; Dolezel M
J Chemother; 2004 Nov; 16 Suppl 5():34-6. PubMed ID: 15675474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
